Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

Simona Taverna, Marta Castiglia, Marco Giallombardo, Riccardo Alessandro, Antonio Araujo, Ignacio Gil-Bazo, Marc Peeters, Simona Taverna, Marta Castiglia, Marco Giallombardo, Patrick Pauwels, Jorge Chacártegui, Anna Paola Carreca, Christian Rolfo, Riccardo Alessandro, Christian Diego Rolfo

Risultato della ricerca: Article

49 Citazioni (Scopus)

Abstract

Exosomes are nano-sized vesicles of endolysosomal origin, released by several cytotypes in physiological and pathological conditions. Tumor derived exosomes, interacting with other cells of the tumor microenvironment, modulate tumor progression, angiogenic switch, metastasis, and immune escape. Recently, extracellular vesicles were proposed as excellent biomarkers for disease monitoring and prognosis in cancer patients. Non-small cell lung cancer (NSCLC) has a poor 5-year survival rate due to the delay in the detection of the disease. The majority of patients are diagnosed in an advanced disease stage. Exosomes might be promising beneficial tools as biomarker candidates in the scenario of NSCLC, since they contain both, proteins and miRNAs. The clinical case reported in this manuscript is a proof of concept revealing that NSCLC exosomes and sorted miRNAs might constitute, in a near future, novel biomarkers. This review summarizes the role of exosomes in NSCLC, focusing on the importance of exosomal microRNAs in lung cancer diagnosis and prognosis
Lingua originaleEnglish
pagine (da-a)28748-28760
Numero di pagine13
RivistaOncotarget
Volume7
Stato di pubblicazionePublished - 2016

Fingerprint

Exosomes
Non-Small Cell Lung Carcinoma
MicroRNAs
Serum
Biomarkers
Cellular Microenvironment
Neoplasms
Tumor Microenvironment
Lung Neoplasms
Survival Rate
Neoplasm Metastasis
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology

Cita questo

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice. / Taverna, Simona; Castiglia, Marta; Giallombardo, Marco; Alessandro, Riccardo; Araujo, Antonio; Gil-Bazo, Ignacio; Peeters, Marc; Taverna, Simona; Castiglia, Marta; Giallombardo, Marco; Pauwels, Patrick; Chacártegui, Jorge; Carreca, Anna Paola; Rolfo, Christian; Alessandro, Riccardo; Rolfo, Christian Diego.

In: Oncotarget, Vol. 7, 2016, pag. 28748-28760.

Risultato della ricerca: Article

Taverna, S, Castiglia, M, Giallombardo, M, Alessandro, R, Araujo, A, Gil-Bazo, I, Peeters, M, Taverna, S, Castiglia, M, Giallombardo, M, Pauwels, P, Chacártegui, J, Carreca, AP, Rolfo, C, Alessandro, R & Rolfo, CD 2016, 'Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice', Oncotarget, vol. 7, pagg. 28748-28760.
Taverna, Simona ; Castiglia, Marta ; Giallombardo, Marco ; Alessandro, Riccardo ; Araujo, Antonio ; Gil-Bazo, Ignacio ; Peeters, Marc ; Taverna, Simona ; Castiglia, Marta ; Giallombardo, Marco ; Pauwels, Patrick ; Chacártegui, Jorge ; Carreca, Anna Paola ; Rolfo, Christian ; Alessandro, Riccardo ; Rolfo, Christian Diego. / Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice. In: Oncotarget. 2016 ; Vol. 7. pagg. 28748-28760.
@article{108c2a2af1a146f0b58933f7f0a3bbe5,
title = "Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice",
abstract = "Exosomes are nano-sized vesicles of endolysosomal origin, released by several cytotypes in physiological and pathological conditions. Tumor derived exosomes, interacting with other cells of the tumor microenvironment, modulate tumor progression, angiogenic switch, metastasis, and immune escape. Recently, extracellular vesicles were proposed as excellent biomarkers for disease monitoring and prognosis in cancer patients. Non-small cell lung cancer (NSCLC) has a poor 5-year survival rate due to the delay in the detection of the disease. The majority of patients are diagnosed in an advanced disease stage. Exosomes might be promising beneficial tools as biomarker candidates in the scenario of NSCLC, since they contain both, proteins and miRNAs. The clinical case reported in this manuscript is a proof of concept revealing that NSCLC exosomes and sorted miRNAs might constitute, in a near future, novel biomarkers. This review summarizes the role of exosomes in NSCLC, focusing on the importance of exosomal microRNAs in lung cancer diagnosis and prognosis",
author = "Simona Taverna and Marta Castiglia and Marco Giallombardo and Riccardo Alessandro and Antonio Araujo and Ignacio Gil-Bazo and Marc Peeters and Simona Taverna and Marta Castiglia and Marco Giallombardo and Patrick Pauwels and Jorge Chac{\'a}rtegui and Carreca, {Anna Paola} and Christian Rolfo and Riccardo Alessandro and Rolfo, {Christian Diego}",
year = "2016",
language = "English",
volume = "7",
pages = "28748--28760",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",

}

TY - JOUR

T1 - Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

AU - Taverna, Simona

AU - Castiglia, Marta

AU - Giallombardo, Marco

AU - Alessandro, Riccardo

AU - Araujo, Antonio

AU - Gil-Bazo, Ignacio

AU - Peeters, Marc

AU - Taverna, Simona

AU - Castiglia, Marta

AU - Giallombardo, Marco

AU - Pauwels, Patrick

AU - Chacártegui, Jorge

AU - Carreca, Anna Paola

AU - Rolfo, Christian

AU - Alessandro, Riccardo

AU - Rolfo, Christian Diego

PY - 2016

Y1 - 2016

N2 - Exosomes are nano-sized vesicles of endolysosomal origin, released by several cytotypes in physiological and pathological conditions. Tumor derived exosomes, interacting with other cells of the tumor microenvironment, modulate tumor progression, angiogenic switch, metastasis, and immune escape. Recently, extracellular vesicles were proposed as excellent biomarkers for disease monitoring and prognosis in cancer patients. Non-small cell lung cancer (NSCLC) has a poor 5-year survival rate due to the delay in the detection of the disease. The majority of patients are diagnosed in an advanced disease stage. Exosomes might be promising beneficial tools as biomarker candidates in the scenario of NSCLC, since they contain both, proteins and miRNAs. The clinical case reported in this manuscript is a proof of concept revealing that NSCLC exosomes and sorted miRNAs might constitute, in a near future, novel biomarkers. This review summarizes the role of exosomes in NSCLC, focusing on the importance of exosomal microRNAs in lung cancer diagnosis and prognosis

AB - Exosomes are nano-sized vesicles of endolysosomal origin, released by several cytotypes in physiological and pathological conditions. Tumor derived exosomes, interacting with other cells of the tumor microenvironment, modulate tumor progression, angiogenic switch, metastasis, and immune escape. Recently, extracellular vesicles were proposed as excellent biomarkers for disease monitoring and prognosis in cancer patients. Non-small cell lung cancer (NSCLC) has a poor 5-year survival rate due to the delay in the detection of the disease. The majority of patients are diagnosed in an advanced disease stage. Exosomes might be promising beneficial tools as biomarker candidates in the scenario of NSCLC, since they contain both, proteins and miRNAs. The clinical case reported in this manuscript is a proof of concept revealing that NSCLC exosomes and sorted miRNAs might constitute, in a near future, novel biomarkers. This review summarizes the role of exosomes in NSCLC, focusing on the importance of exosomal microRNAs in lung cancer diagnosis and prognosis

UR - http://hdl.handle.net/10447/176108

M3 - Article

VL - 7

SP - 28748

EP - 28760

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

ER -